Leadership Overview
Hikma Pharmaceuticals has 7 executives leading key functions including strategy, information technology, operations, finance, and corporate development.
Driven by a commitment to improving health, Hikma Pharmaceuticals manufactures branded and non-branded generic and in-licensed pharmaceutical products, impacting global healthcare markets through its extensive product portfolio and strategic growth initiatives.
Driven by a commitment to improving health, Hikma Pharmaceuticals manufactures branded and non-branded generic and in-licensed pharmaceutical products, impacting global healthcare markets through its extensive product portfolio and strategic growth initiatives.
Leadership Roles at Hikma Pharmaceuticals
Said Darwazah - Chief Executive Officer
Said Darwazah, the Chief Executive Officer at Hikma Pharmaceuticals, directs the company's overall strategic vision and operational execution. Overseeing global operations, the Chief Executive Officer ensures alignment with corporate objectives for manufacturing and distributing pharmaceutical products. This leadership role involves expanding market share through strategic product development and market penetration. By optimizing the company's global footprint, Said Darwazah directly impacts Hikma's growth and financial stability. Ultimately, Darwazah secures long-term success for the multinational pharmaceutical entity, driving innovation and accessibility in healthcare markets worldwide. The Chief Executive Officer's purview encompasses all divisions, ensuring cohesive strategy and efficient resource allocation across the organization. This executive's leadership is central to Hikma's mission of improving lives through high-quality, affordable medicines.
Areb Kurdi - Acting Chief Financial Officer
Areb Kurdi, the Acting Chief Financial Officer at Hikma Pharmaceuticals, manages the company's financial operations and strategic fiscal planning. Overseeing financial reporting, budgeting, and capital allocation, the Acting Chief Financial Officer ensures fiscal integrity and supports sustainable growth initiatives. This leadership role involves providing critical financial insights to guide executive decision-making and optimize resource deployment across global markets. By maintaining stringent financial controls, Areb Kurdi directly impacts Hikma's profitability and investor confidence. Ultimately, Kurdi guides the financial strategy to ensure the company's long-term economic health and operational resilience. The Acting Chief Financial Officer's responsibilities include managing relationships with financial institutions and ensuring compliance with all relevant financial regulations.
Ala'a Habboub - Chief Financial Officer (Jordan)
Ala'a Habboub, the Chief Financial Officer (Jordan) at Hikma Pharmaceuticals, directs financial strategy and management for operations based in Jordan. Overseeing financial planning, accounting, and treasury functions within the Jordanian market, the Chief Financial Officer (Jordan) ensures accurate financial reporting and compliance with local regulations. This leadership role involves optimizing financial performance and resource allocation to support Hikma's strategic objectives in the region. By managing financial resources effectively, Ala'a Habboub directly impacts the profitability and operational efficiency of the Jordanian division. Ultimately, Habboub strengthens the financial foundation of Hikma's operations in Jordan, contributing to the company's overall success. The Chief Financial Officer (Jordan)'s purview includes developing financial models to support business growth and investment opportunities.
Tareq Darwazeh - Chief Operating Officer (MENA Region)
Tareq Darwazeh, the Chief Operating Officer (MENA Region) at Hikma Pharmaceuticals, spearheads operational excellence across the Middle East and North Africa. Overseeing manufacturing, supply chain, and distribution networks within the MENA region, the Chief Operating Officer (MENA Region) ensures efficient production and timely delivery of pharmaceutical products. This leadership role involves optimizing regional operations to meet local market demands and regulatory requirements. By enhancing regional operational capabilities, Tareq Darwazeh directly impacts Hikma's market presence and revenue generation in key growth territories. Ultimately, Darwazeh drives operational efficiency and strategic execution within the MENA region, solidifying Hikma's position as a leading pharmaceutical provider. The Chief Operating Officer (MENA Region)'s focus includes expanding production capacity and improving logistical frameworks to serve a growing patient population.
Patricia Bousfield - Chief Information Officer
Patricia Bousfield, the Chief Information Officer at Hikma Pharmaceuticals, architects the company's technology strategy and digital transformation initiatives. Overseeing all IT infrastructure and cybersecurity measures, the Chief Information Officer ensures robust and secure data management systems that support global operations. This leadership role involves implementing innovative technological solutions to enhance operational efficiency and product development pipelines. By optimizing digital platforms, Patricia Bousfield directly impacts Hikma's ability to leverage data for strategic decision-making and market responsiveness. Ultimately, Bousfield safeguards the company's digital assets and drives technological advancements essential for maintaining a competitive edge in the pharmaceutical sector. The Chief Information Officer's responsibilities extend to fostering a culture of digital innovation across all departments, ensuring seamless integration of technology into business processes.
Bassam Kanaan - Executive VP, Corporate Development Mergers & Acquisitions
Bassam Kanaan, the Executive VP, Corporate Development Mergers & Acquisitions at Hikma Pharmaceuticals, drives strategic growth through identifying and executing mergers and acquisitions. Overseeing the evaluation of potential acquisition targets and managing the negotiation and integration processes, the Executive VP, Corporate Development Mergers & Acquisitions ensures alignment with Hikma's long-term expansion strategy. This leadership role involves assessing market opportunities and financial viability to fuel company growth and enhance its product portfolio. By strategically expanding the company's reach through acquisitions, Bassam Kanaan directly impacts Hikma's market position and competitive advantage. Ultimately, Kanaan shapes the future trajectory of Hikma by securing key strategic partnerships and acquisitions that bolster its global presence. The Executive VP, Corporate Development Mergers & Acquisitions's expertise is critical in navigating complex deal structures and maximizing value from strategic investments.
Chawki Sabri - Finnance
Chawki Sabri, the Finnance at Hikma Pharmaceuticals, contributes to the company's financial operations and strategic fiscal management. Overseeing specific financial functions, the Finnance ensures the accuracy and efficiency of financial processes that support Hikma's global business objectives. This role involves collaborating with finance teams to implement sound financial practices and reporting standards. By supporting robust financial systems, Chawki Sabri directly impacts the integrity of financial data and contributes to informed decision-making. Ultimately, Sabri plays a part in maintaining the financial health and operational stability of the organization. The Finnance's responsibilities are integral to the smooth functioning of the company's financial department, ensuring adherence to established protocols.
Explore Leadership Teams in Manufacturing
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
MM
MP
CM
Torrent Pharmaceuticals Ltd is the flagship enterprise of the Torrent Group and stands among the leading pharmaceutical companies in India, with a strong and growing international presence. The company is widely recognized for its leadership across key therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, vitamins, minerals and nutritionals, and cosmo-dermatology, while also maintaining a meaningful footprint in diabetology, pain management, gynaecology, oncology and anti-infective treatments. Built on a foundation of scientific excellence and innovation, Torrent Pharma places research and development at the core of its strategy, supported by advanced infrastructure and a highly skilled scientific workforce dedicated to developing high-quality, affordable medicines for patients worldwide.
Company Leadership AJ
AV
VG
Amrutanjan Health Care Ltd specializes in pain and congestion management products, including aromatic balms, roll-ons, and sprays. Founded in 1893, the company is dedicated to enhancing people's well-being by combining natural extracts with scientific research to create effective, side-effect-free solutions. Their product range caters to various needs, including headache relief, body pain management, and women's hygiene. Amrutanjan aims to serve a global consumer base while maintaining a commitment to sustainability and health.
Company Leadership PD
MB
TJ
JC
Kite Pharma, founded in 2009, is a pharmaceutical company specializing in cell therapy to treat and potentially cure cancer. The company focuses on engineered T cell therapy for hematologic malignancies and is committed to making these innovative treatments accessible to eligible patients. Unlike traditional pharmaceutical manufacturing, Kite Pharma's approach involves reengineering a patient's own immune cells to fight cancer cells individually. The company operates dedicated cell therapy manufacturing facilities in California, Maryland, and the Netherlands, with corporate headquarters in Santa Monica, California. Kite Pharma continues to advance cancer immunotherapy through its specialized treatments and research.
Company Leadership LM
KD
NS
Frequently Asked Questions Regarding Hikma Pharmaceuticals Top Executives and Leadership Team
